financetom
Business
financetom
/
Business
/
Principal Financial Group Q3 Non-GAAP Operating Earnings Rise; Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Principal Financial Group Q3 Non-GAAP Operating Earnings Rise; Shares Drop After Hours
Nov 3, 2024 11:13 AM

05:35 PM EDT, 10/24/2024 (MT Newswires) -- Principal Financial Group ( PFG ) reported Q3 non-GAAP operating earnings late Thursday of $2.05 per diluted share, up from $1.83 a year earlier.

Analysts polled by Capital IQ expected normalized EPS of $2.01.

The company raised its quarterly dividend $0.01 to $0.73 a share, payable Dec. 18 to investors of record Dec. 2.

The company's shares fell 5% in after-hours trading.

Price: 85.17, Change: -4.48, Percent Change: -5.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Evergold's DEM Prospect Returns High Grades of Antimony in Drilling; Shares down 12%
Dec 11, 2024
09:39 AM EST, 12/11/2024 (MT Newswires) -- Evergold ( EVGUF ) on Wednesday announced assay results for two core holes (DEM24-04 and DEM24-05) completed on the DEM Mountain Zone near Fort St. James, B.C. in early Oct., in follow up to highly encouraging results from an initial 3-hole drill program (DEM23-01,02,03), carried out in fall 2023. The company said the...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
AbbVie Closes Aliada Therapeutics Acquisition
AbbVie Closes Aliada Therapeutics Acquisition
Dec 11, 2024
09:37 AM EST, 12/11/2024 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday it has closed the acquisition of Aliada Therapeutics. The company in October agreed to acquire Aliada Therapeutics for $1.40 billion in cash. Price: 174.85, Change: -0.82, Percent Change: -0.47 ...
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Dec 11, 2024
09:34 AM EST, 12/11/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Wednesday it has bought Georgia-based employee benefits brokerage firm Sheila J. Butler & Co. Financial terms weren't disclosed. Price: 284.17, Change: +0.43, Percent Change: +0.15 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved